fda-panel-rejects-some-claims-for-heat-not-burn-tobacco-device/

fda-panel-rejects-some-claims-for-heat-not-burn-tobacco-device/


Controversial “heat-not-burn” tobacco devices might only get limited marketing in the United States, based on recommendations issued Thursday by an influential government panel.These devices are different than e-cigarettes, in that instead of heating a nicotine-infused liquid, they warm up tobacco to about 500 degrees Fahrenheit, producing an inhalable aerosol.To get more news about iqos, you can visit hitaste official website.

A panel of advisers to the U.S. Food and Drug Administration has been examining an application from tobacco giant Phillip Morris to market such a device, called iQOS, in the United States. The device is already sold in 30 countries.

However, on Thursday the FDA panel rejected Philip Morris’ proposal that it market iQOS as a lower-risk alternative to cigarettes — one that would cut a user’s risk for disease compared to “regular” smoking.But in another decision, the panel said it would endorse a second claim — that iQOS exposes users to lower levels of toxic chemicals compared to cigarettes.

That could open the door to the tobacco company marketing the device in the United States, but in a more restricted way.

The FDA is expected to decide whether Philip Morris can sell iQOS within the next few months. The agency is not obligated to follow the recommendations of its advisory panels, but it usually does.One recent study, published in October, found that in countries where the product is already on the market, like Japan, it has achieved rapid popularity as a smoke-free option for those e-smokers who yearn for the old taste and back-of-throat burning sensation (or “hit”) of traditional cigarettes.

Still, “we don’t know enough about the health implications of heat-not-burn tobacco products, and that lack of knowledge is extremely dangerous for public health,” Theodore Caputi, the study’s lead author, said at the time of publication. He’s a graduate student in public health at the Wharton School at the University of Pennsylvania in Philadelphia.

“We know from experience that the tobacco industry and their allies will not wait for all the facts to begin making health claims,” he added.“We need to first ensure, before heat-not-burn reaches the market, that consumers are aware we don’t have all the facts on heat-not-burn products, and then we should begin filling in those knowledge gaps,” Caputi said.

He said that “considering the absolutely massive public health implications of tobacco products, generally — that is, tobacco use is the leading cause of preventable death — picking up a heat-not-burn device before we have all the facts is not a decision consumers should take lightly.”